XENE
Xenon Pharmaceuticals Inc. · Healthcare
Director Gillian Cannon sold $63K of Xenon Pharmaceuticals Inc.
Sold$63,237
$53.14Price
1,190Shares
−45%Stake
What XENE did after the filing
- The stock from Tue, Jun 9 open, $52.14
- +25.5%
- S&P 500, same days
- −0.7%
Measured over 30 trading days, to the Jul 23 close.
Traded Fri, Jun 5. Filed Mon, Jun 8, 9:19 PM ET, after the close. Returns use the Jun 9 open and the Jul 23 close. Not investment advice.